The Symptoms and Medications of Patients with Inflammatory Bowel Disease in Hubei Province after COVID-19 Epidemic
Table 2
Gastrointestinal, respiratory, and systemic symptoms in IBD patients.
CD
UC
IBDU
Total
%
Gastrointestinal symptoms
Abdominal pain
28
22
0
50
24.51%
Diarrhea
29
22
0
51
25.00%
Nausea and vomiting
3
4
0
7
3.43%
Bloody stools
4
28
0
32
15.69%
Perianal discomfort
16
17
0
33
16.18%
Total
54
52
0
106
51.96%
Systemic symptoms
Fever
6
4
0
10
4.90%
Fatigue
18
12
0
30
14.71%
Listlessness
19
16
0
35
17.16%
Headache
4
5
0
9
4.41%
Muscle pain
8
7
0
15
7.35%
Palpitations
2
4
0
6
2.94%
Total
30
26
0
56
27.45%
Respiratory symptoms
Stuffy nose
5
4
1
10
8.82%
Nasal discharge
5
2
1
8
4.90%
Cough
2
2
0
4
3.92%
Sputum production
2
1
0
3
1.96%
Chest pain
0
1
1
2
1.47%
Total
11
5
2
18
8.82%
The numbers of patients with gastrointestinal, respiratory, or systemic symptoms were showed in different subtypes of IBD. Total numbers and percentage were displayed in the last two columns.
